University Hospitals Birmingham NHS Foundation Trust

Loading results...
View full results list

Medicines A–Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

T

Status	Drug name	NICE TAs	Comments
	Temozolomide capsules	TA121 - Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma TA23 - Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)
	Temsirolimus infusion (Torisel®)	TA207 - Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal) (Negative TA) TA178 - Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma (Negative TA)	Hospital use only
	Tenecteplase injection	TA52 - Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction	Hospital use only
	Terbinafine 1% cream
	Terbutaline
	Terbutaline inhaler
	Terbutaline nebulised		As an alternative to salbutamol nebules if salbutamol is in short supply
	Teriflunomide	TA303 - Teriflunomide for treating relapsing–remitting multiple sclerosis
	Teriparatide injection	TA161 - Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women
	Terlipressin injection		Hospital use only

Building healthier lives